Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 25, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026